SciELO - Scientific Electronic Library Online

 
vol.43 número4Decrease in the intensive care unit-acquired weakness with a multicomponent protocol implementation: A quasi-experimental clinical trialUpdate of antimicrobial resistance in level III and IV health institutions in Colombia between January 2018 and December 2021 índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Biomédica

versão impressa ISSN 0120-4157versão On-line ISSN 2590-7379

Resumo

PUERTO, Gloria Mercedes et al. Drug-resistant tuberculosis in Colombia, 2013-2018: Case-control study. Biomed. [online]. 2023, vol.43, n.4, pp.447-456.  Epub 01-Dez-2023. ISSN 0120-4157.  https://doi.org/10.7705/biomedica.6842.

Introduction.

Multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) is difficult to control, has high morbidity and mortality, and demands priority public health intervention. In Colombia, MDR/RR-TB has been becoming more widespread annually. Before the COVID-19 pandemic, over an 8-year period, the number of cases of multidrug-resistant tuberculosis in Colombia was close to a thousand cases. Timely identification of the different risk factors for MDR/RR-TB will contribute fundamentally to the systematic management.

Objective.

To determine which risk factors were associated with the presentation of MDR in Colombia between 2013 and 2018.

Materials and methods.

A retrospective case-control study was carried out, for which the data from the routine surveillance of MDR/events in the country were used.

Results.

The cases of multidrug-resistant tuberculosis were mainly in young people, Afrodescendants, and males. Of the clinical conditions, comorbidities such as malnutrition, diabetes, and HIV, presence of at least one factor, such as drug dependence, taking immunosuppressive medications, belonging to the black race, afro, and living in an area of high disease burden were risk factors.

Conclusion.

In addition to the diagnosis and timely provision of MDR-TB treatment, it is necessary that public health programs at the local level pay special attention to patients with the identified risk factors.

Palavras-chave : tuberculosis; drug resistance, multiple; risk factors; retrospective studies; comorbidities; case-control studies; black people.

        · resumo em Espanhol     · texto em Inglês     · Inglês ( pdf )